CHEK
Price
$1.55
Change
-$0.70 (-31.11%)
Updated
Dec 24, 02:00 PM (EDT)
64 days until earnings call
NVNO
Price
$2.82
Change
-$0.09 (-3.09%)
Updated
Dec 24, 02:00 PM (EDT)
65 days until earnings call
Ad is loading...

CHEK vs NVNO

Header iconCHEK vs NVNO Comparison
Open Charts CHEK vs NVNOBanner chart's image
Check-Cap
Price$1.55
Change-$0.70 (-31.11%)
Volume$7.61K
CapitalizationN/A
enVVeno Medical
Price$2.82
Change-$0.09 (-3.09%)
Volume$1.63K
CapitalizationN/A
CHEK vs NVNO Comparison Chart
Loading...
CHEK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NVNO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CHEK vs. NVNO commentary
Dec 25, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CHEK is a Hold and NVNO is a Hold.

Ad is loading...
COMPARISON
Comparison
Dec 25, 2024
Stock price -- (CHEK: $2.25 vs. NVNO: $2.91)
Brand notoriety: CHEK and NVNO are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: CHEK: 4385% vs. NVNO: 107%
Market capitalization -- CHEK: $18.19M vs. NVNO: $72.44M
CHEK [@Medical Specialties] is valued at $18.19M. NVNO’s [@Medical Specialties] market capitalization is $72.44M. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.04B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CHEK’s FA Score shows that 1 FA rating(s) are green whileNVNO’s FA Score has 1 green FA rating(s).

  • CHEK’s FA Score: 1 green, 4 red.
  • NVNO’s FA Score: 1 green, 4 red.
According to our system of comparison, both CHEK and NVNO are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CHEK’s TA Score shows that 5 TA indicator(s) are bullish while NVNO’s TA Score has 4 bullish TA indicator(s).

  • CHEK’s TA Score: 5 bullish, 4 bearish.
  • NVNO’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, CHEK is a better buy in the short-term than NVNO.

Price Growth

CHEK (@Medical Specialties) experienced а +265.85% price change this week, while NVNO (@Medical Specialties) price change was +1.75% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +1.04%. For the same industry, the average monthly price growth was +1.41%, and the average quarterly price growth was +2.73%.

Reported Earning Dates

CHEK is expected to report earnings on Feb 26, 2025.

NVNO is expected to report earnings on Feb 27, 2025.

Industries' Descriptions

@Medical Specialties (+1.04% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NVNO($72.4M) has a higher market cap than CHEK($18.2M). CHEK YTD gains are higher at: 8.173 vs. NVNO (-43.385). CHEK has higher annual earnings (EBITDA): -18.8M vs. NVNO (-24.69M). NVNO has more cash in the bank: 46.4M vs. CHEK (32.1M). CHEK has less debt than NVNO: CHEK (83K) vs NVNO (1.4M). CHEK (0) and NVNO (0) have equivalent revenues.
CHEKNVNOCHEK / NVNO
Capitalization18.2M72.4M25%
EBITDA-18.8M-24.69M76%
Gain YTD8.173-43.385-19%
P/E RatioN/AN/A-
Revenue00-
Total Cash32.1M46.4M69%
Total Debt83K1.4M6%
FUNDAMENTALS RATINGS
CHEK vs NVNO: Fundamental Ratings
CHEK
NVNO
OUTLOOK RATING
1..100
9951
VALUATION
overvalued / fair valued / undervalued
1..100
28
Undervalued
31
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9798
PRICE GROWTH RATING
1..100
9694
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
2850

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CHEK's Valuation (28) in the Medical Specialties industry is in the same range as NVNO (31) in the null industry. This means that CHEK’s stock grew similarly to NVNO’s over the last 12 months.

CHEK's Profit vs Risk Rating (100) in the Medical Specialties industry is in the same range as NVNO (100) in the null industry. This means that CHEK’s stock grew similarly to NVNO’s over the last 12 months.

CHEK's SMR Rating (97) in the Medical Specialties industry is in the same range as NVNO (98) in the null industry. This means that CHEK’s stock grew similarly to NVNO’s over the last 12 months.

NVNO's Price Growth Rating (94) in the null industry is in the same range as CHEK (96) in the Medical Specialties industry. This means that NVNO’s stock grew similarly to CHEK’s over the last 12 months.

NVNO's P/E Growth Rating (100) in the null industry is in the same range as CHEK (100) in the Medical Specialties industry. This means that NVNO’s stock grew similarly to CHEK’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CHEKNVNO
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
81%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 2 days ago
83%
Momentum
ODDS (%)
Bullish Trend 2 days ago
67%
Bearish Trend 2 days ago
88%
MACD
ODDS (%)
Bullish Trend 2 days ago
73%
Bearish Trend 2 days ago
84%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
73%
Bullish Trend 2 days ago
78%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
74%
Bearish Trend 2 days ago
84%
Advances
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 9 days ago
80%
Declines
ODDS (%)
Bearish Trend 6 days ago
90%
Bearish Trend 5 days ago
86%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
77%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
88%
View a ticker or compare two or three
Ad is loading...
CHEK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NVNO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CBOE193.101.49
+0.78%
Cboe Global Markets
BXMT18.02-0.13
-0.72%
Blackstone Mortgage Trust
GSM3.79-0.08
-2.07%
Ferroglobe PLC
SQFT0.79-0.06
-7.06%
Presidio Property Trust
GOEV0.08-0.01
-7.71%
Canoo Inc

CHEK and

Correlation & Price change

A.I.dvisor tells us that CHEK and NVNO have been poorly correlated (+27% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CHEK and NVNO's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CHEK
1D Price
Change %
CHEK100%
+281.36%
NVNO - CHEK
27%
Poorly correlated
+16.87%
IINN - CHEK
26%
Poorly correlated
+30.32%
TWST - CHEK
26%
Poorly correlated
+0.38%
RSLS - CHEK
26%
Poorly correlated
-2.74%
ICAD - CHEK
26%
Poorly correlated
-7.92%
More

NVNO and

Correlation & Price change

A.I.dvisor indicates that over the last year, NVNO has been loosely correlated with CUTR. These tickers have moved in lockstep 33% of the time. This A.I.-generated data suggests there is some statistical probability that if NVNO jumps, then CUTR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NVNO
1D Price
Change %
NVNO100%
+16.87%
CUTR - NVNO
33%
Loosely correlated
-10.01%
ILMN - NVNO
27%
Poorly correlated
-0.76%
WAT - NVNO
27%
Poorly correlated
+0.43%
CHEK - NVNO
27%
Poorly correlated
+281.36%
GENE - NVNO
25%
Poorly correlated
N/A
More